Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (<scp>KRd</scp>) versus bortezomib, lenalidomide, and dexamethasone (<scp>VRd</scp>) in newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis
American journal of hematology